Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Go back to Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204
(AMEX: MBCOF) Delayed: 0.11 -0.01 (8.33%)
Previous Close $0.12    52 Week High
Open $0.11    52 Week Low
Day High $0.11    P/E N/A 
Day Low $0.11    EPS
Volume 5,000